Work

Supplementary Figure 1 from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 1 from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
Language: English
Subfield: Genetics
Open Access status: gold
OpenAlex ID: W4361250805
Cites:
Cited by:
Related to: 10